Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EUROAPI Reports Progressive Restart of Prostaglandin Production | Contract Pharma
Breaking News

EUROAPI Reports Progressive Restart of Prostaglandin Production

Majority of production at the Budapest site expected to be back online by mid-April 2023.

EUROAPI progressively restarted prostaglandin production at its Budapest site on January 19, 2023.

As first reported in its press release of December 7, 2022, EUROAPI identified certain Good Manufacturing Practices deficiencies related to production documentation during an internal assessment and decided to temporarily suspend prostaglandin activities at its Budapest site.

The company said it has built and implemented a remediation plan, allowing to progressively restart prostaglandin production in January. As the restart is progressive in nature by design, EUROAPI expects the majority of prostaglandin production to be back online by mid-April 2023.

As anticipated, no other activities at the Budapest site were impacted, including contract development and manufacturing organization (CDMO) activities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters